Literature DB >> 35309877

Doppler Ultrasound in the Management of Vascular Complications Associated with Hyaluronic Acid Dermal Fillers.

Marco Antonio Munia1, Christine Guarnieri Munia1, Meire Brasil Parada1, Jose Ben-Hurferraz Parente1, Nelson Wolosker1.   

Abstract

Facial injections with hyaluronic acid (HA) dermal fillers have become increasingly common. Hyaluronic acid is currently the most frequently used dermal filler. When compared to collagen for the treatment of nasolabial folds, HA not only produces similar cosmetic results with smaller doses but also lasts longer. Our objective was to evaluate the results of 10 patients with vascular complications associated with HA fillers treated with ultrasound-guided injection of hyaluronidase (HYAL) according to the Brazilian Society of Dermatology guidelines. Admission clinical evaluation revealed that the most frequent signs were: livedo reticularis (100% of the patients), hypoesthesia (50%) and local pain (20%). Although 80% of the patients complained of local pain during HYAL injection, none of them persisted with pain after the procedure ended. The total dose of injected HYAL per patient ranged from 300 to 750 IU (mean 500 IU). Post-HYAL treatment Doppler ultrasound showed pervious facial arteries and veins in 100% of the patients.
Copyright © 2022. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Hyaluronic acid; complications; fillers; ultrasound

Year:  2022        PMID: 35309877      PMCID: PMC8884183     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  11 in total

1.  Arterial embolization caused by injection of hyaluronic acid (Restylane).

Authors:  N J Lowe
Journal:  Br J Dermatol       Date:  2003-02       Impact factor: 9.302

2.  Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase.

Authors:  Ranella J Hirsch; Joel L Cohen; Jean D A Carruthers
Journal:  Dermatol Surg       Date:  2007-03       Impact factor: 3.398

Review 3.  Complications following injection of soft-tissue fillers.

Authors:  Cemile Nurdan Ozturk; Yumeng Li; Rebecca Tung; Lydia Parker; Melissa Peck Piliang; James E Zins
Journal:  Aesthet Surg J       Date:  2013-07-03       Impact factor: 4.283

4.  Transarterial degradation of hyaluronic acid filler by hyaluronidase.

Authors:  Claudio DeLorenzi
Journal:  Dermatol Surg       Date:  2014-08       Impact factor: 3.398

5.  Efficacy and Safety of Alprostadil in Patients with Peripheral Arterial Occlusive Disease Fontaine Stage IV: Results of a Placebo Controlled Randomised Multicentre Trial (ESPECIAL).

Authors:  H Lawall; A Pokrovsky; P Checinski; A Ratushnyuk; G Hamm; O Randerath; F Grieger; J W G Bentz
Journal:  Eur J Vasc Endovasc Surg       Date:  2017-02-08       Impact factor: 7.069

Review 6.  Consensus statement on prevention and management of adverse effects following rejuvenation procedures with hyaluronic acid-based fillers.

Authors:  W G Philipp-Dormston; D Bergfeld; B M Sommer; G Sattler; S Cotofana; P Snozzi; U Wollina; K P J Hoffmann; C Salavastru; K Fritz
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-06-15       Impact factor: 6.166

7.  Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase.

Authors:  Ranella J Hirsch; Mary Lupo; Joel L Cohen; David Duffy
Journal:  J Drugs Dermatol       Date:  2007-03       Impact factor: 2.114

8.  New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events.

Authors:  Claudio DeLorenzi
Journal:  Aesthet Surg J       Date:  2017-07-01       Impact factor: 4.283

Review 9.  Contemporary review of injectable facial fillers.

Authors:  Theda C Kontis
Journal:  JAMA Facial Plast Surg       Date:  2013-01       Impact factor: 4.611

Review 10.  Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers.

Authors:  Paul C Edwards; John E Fantasia
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more
  1 in total

Review 1.  Bridging a Century-Old Problem: The Pathophysiology and Molecular Mechanisms of HA Filler-Induced Vascular Occlusion (FIVO)-Implications for Therapeutic Interventions.

Authors:  Danny J Soares
Journal:  Molecules       Date:  2022-08-24       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.